FGF21 and metabolic syndrome: As we known, the increased circulating FGF21 levels were positively correlated with metabolic syndrome in obese population (24), because the physiological increased dose of circulating FGF21 helps to maintain insulin sensitivity in specific tissues during the early stages of these diseases (25).